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Introduction
Persistent organic pollutants (POPs) are 
organic compounds of anthropogenic origin 
that resist degradation and accumulate in the 
food chain (Agency for Toxic Substances and 
Disease Registry 2000). Exposure to POPs 
during critical periods in fetal life may alter 
the development of the neuroendocrine and 
other systems (Grandjean and Landrigan 
2006). Early exposure to polychlorinated 
biphenyls (PCBs) in experimental studies 
produces auditory system impairment 
(Crofton and Rice 1999; Crofton et al. 
2000a, 2000b; Goldey et al. 1995; Herr et al. 
1996; Powers et al. 2006). In studies of rats, 
ototoxicity involves early postnatal exposure 
to PCBs via lactation, an up‑regulation of 
hepatic uridine diphospho‑glucuronosyl‑
transferases, and subsequent hypothyroxi‑
nemia during a critical period of cochlear 
development (Crofton and Zoeller 2005). 
For instance, distortion product otoacoustic 
emissions in 18‑month‑old rodents were 
reduced in amplitude and thresholds were 
increased after exposure of the pregnant dams 
to a PCB mixture (Aroclor 1254) (Lasky 
et al. 2002).
Previous studies of the association between 
PCB exposure and measures of hearing 
in children have produced mixed results. 
For example, among participants in the 
Collaborative Perinatal Project, maternal PCB 
concentration in pregnancy was not associ‑
ated with sensorineural hearing loss at 8 years 
of age (Longnecker et al. 2004). In contrast 
to these null results, higher cord blood PCB 
concentrations were associated with a higher 
hearing threshold on audiometry at 7 years of 
age in a cohort of children in the Faroe Islands 
(Grandjean et al. 2001). Although both of 
these studies focused on in utero exposure 
to PCBs, previous studies of children and 
adolescents living in a highly polluted area 
of eastern Slovakia showed adverse associa‑
tions between PCB concentrations measured 
concurrently with otoacoustic emissions 
(OAEs) during childhood (Trnovec et al. 
2008, 2010). Previously published studies 
have not examined both in utero and postnatal 
PCB concentrations in relation to measures 
of child hearing. The repeated measures of 
PCB concentration in the present study allows 
examination of multiple exposure time points 
in relation to hearing outcomes in childhood.
Materials and Methods 
Study population and follow-up. This report 
is based on an ongoing birth cohort study in 
eastern Slovakia that enrolled 1,134 mother–
infant pairs during 2002–2004 (Hertz‑
Picciotto et al. 2003). Initial participants were 
recruited from two districts: Michalovce, 
which has high PCB contamination in the 
environment from a chemical manufacturing 
plant (n = 812); and Stropkov/Svidnik, 
located 66 km to the northwest, which 
has lower environmental levels of PCBs 
(n = 322). Mothers gave informed consent 
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Background: Some experimental and human data suggest that exposure to polychlorinated 
biphenyls (PCBs) may induce ototoxicity, though results of previous epidemiologic studies are 
mixed and generally focus on either prenatal or postnatal PCB concentrations exclusively.
oBjectives: Our aim was to evaluate the association between pre- and postnatal PCB 
concentrations in relation to cochlear status, assessed by distortion product otoacoustic emissions 
(DPOAEs), and to further clarify the critical periods in development where cochlear status may be 
most susceptible to PCBs.
Methods: A total of 351 children from a birth cohort in eastern Slovakia underwent otoacoustic 
testing at 45 months of age. Maternal pregnancy, cord, and child 6-, 16-, and 45-month blood 
samples were collected and analyzed for PCB concentrations. At 45 months of age, DPOAEs 
were assessed at 11 frequencies in both ears. Multivariate, generalized linear models were used to 
estimate the associations between PCB concentrations at different ages and DPOAEs, adjusting for 
potential confounders.
results: Maternal and cord PCB-153 concentrations were not associated with DPOAEs at 
45 months. Higher postnatal PCB concentrations at 6-, 16-, and 45-months of age were associated 
with lower (poorer) DPOAE amplitudes. When all postnatal PCB exposures were considered as 
an area-under-the-curve metric, an increase in PCB-153 concentration from the 25th to the 75th 
percentile was associated with a 1.6-dB SPL (sound pressure level) decrease in DPOAE amplitude 
(95% CI: –2.6, –0.5; p = 0.003).
conclusions: In this study, postnatal rather than maternal or cord PCB concentrations were 
associated with poorer performance on otoacoustic tests at age 45 months.
citation: Jusko TA, Sisto R, Iosif AM, Moleti A, Wimmerová S, Lancz K, Tihányi J, Šovčíková E, 
Drobná B, Palkovičová L, Jurečková D, Thevenet-Morrison K, Verner MA, Sonneborn D, Hertz-
Picciotto I, Trnovec T. 2014. Prenatal and postnatal serum PCB concentrations and cochlear 
function in children at 45 months of age. Environ Health Perspect 122:1246–1252; http://dx.doi.
org/10.1289/ehp.1307473
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and were enrolled at the time they came 
to the hospital for delivery. The protocol 
excluded a) mothers with more than four 
previous births, b) mothers < 18 years of age, 
c) mothers who had resided < 5 years in their 
district, and d) mothers with a major illness 
during pregnancy. Following the births, we 
also excluded mothers whose infants had 
severe birth defects. Follow‑up occurred 
at 6 and 16 months of age for the entire 
cohort, and at 45 months, it was limited to 
children in the Michalovce district. Thus, no 
data from the Stropkov/Svidnik district are 
included in the present analysis. Of the 812 
mother–infant pairs initially enrolled from 
the Michalovce district at birth, 441 (54%) 
underwent auditory testing at 45 months; 
the remaining mother–infant pairs declined 
to participate or were lost to follow‑up. The 
study protocol was approved by institutional 
review boards at the University of California, 
Davis, and the Slovak Medical University.
Exposure assessment. During the mother’s 
delivery hospital stay, two 9‑mL vacutainer 
tubes were used to collect maternal blood for 
PCB and lipid determination, and cord blood 
was collected just after delivery. The 6‑, 16‑, 
and 45‑month blood draws took place at the 
hospital pediatrics department, where up to 
9 mL of blood was collected for PCB and 
lipid analysis. Details on the handling of spec‑
imens and the isolation of serum have been 
presented elsewhere (Jusko et al. 2010; Park 
et al. 2008). Fifteen PCB congeners [IUPAC 
(International Union of Pure and Applied 
Chemistry) numbers 28, 52, 101, 105, 114, 
118, 123+149, 138+163, 153, 156+171, 157, 
167, 170, 180, and 189] were determined 
in maternal and infant/child serum samples. 
The procedure for determination of PCB 
concentrations involved extraction, cleanup, 
and quantitation by high‑resolution gas chro‑
matography with electron capture detection, 
as described previously (Conka et al. 2005; 
Jusko et al. 2010; Kočan et al. 1994). For 
a portion of 6‑month samples (8%), high‑
resolution mass spectrometry was used to 
quantitate PCB concentrations (Chovancová 
et al. 2012). To ensure that analysis type (gas 
chromatography vs. mass spectrometry) did 
not bias our 6‑month results, we ran an addi‑
tional 6‑month PCB model, which added 
an indicator variable for method of analysis. 
The “method‑adjusted” PCB hearing estimate 
was identical to the estimate without adjust‑
ment for analysis method, suggesting that the 
analysis method did not confound the asso‑
ciation; thus, this variable was not considered 
further. Wet‑weight concentrations (nano‑
grams per milliliter) were determined at the 
Department of Toxic Organic Pollutants at 
the Slovak Medical University in Bratislava. 
This laboratory serves as the National 
Reference Laboratory for Dioxins and Related 
Compounds for the Slovak Republic and 
has been certified by the Slovak National 
Accreditation Service (ISO/IEC 17025:2005, 
certification no. S‑111). Further, this labora‑
tory regularly participates in interlaboratory 
comparison tests, such as the Intercomparison 
Programme (German External Quality 
Assessment Scheme) (G‑EQUAS 2009) and 
the Interlaboratory Quality Assessment coor‑
dinated by the World Health Organization 
(2000). Total serum lipids were measured 
at a commercial laboratory (Alpha Medical, 
Bratislava, Slovakia) accredited by the Slovak 
National Accreditation Service (ISO/IEC 
15189:2007). Total lipid concentrations were 
estimated using the enzymatic summation 
method (Akins et al. 1989).
Otologic and audiological assessments. At 
age 45 months, 441 children initially under‑
went otological and auditory testing as part 
of their participation in this study of PCBs, 
in the Department of Otorhinolaryngology 
at the Michalovce district hospital. First, an 
otorhinolaryngologist conducted an otoscopic 
examination on all children to ensure that 
the ear was free of infection and obstructions. 
After examination of the outer and middle 
ear, tympanometry (GSI 38 Auto Tymp; 
Grason‑Stadler Inc., Milford, NH, USA) was 
employed as a means of screening children for 
middle ear function. All tympanometric assess‑
ments were conducted in a sound‑proof room 
by the head nurse in the otorhinolaryngology 
department. Tympanograms were scored based 
on Jerger’s classification (Jerger 1970), which 
is a tool for clinical interpretation of middle 
ear pathology. As a general rule, in children 
with tympanograms classified as “B,” middle 
ear pathology may be indicated (e.g., fluid or 
infection behind the eardrum or a perfora‑
tion of the eardrum), and proper otoacoustic 
emissions may not be recorded. For a small 
proportion of children in our study (7%), both 
ears were classified as “B.” We nevertheless 
attempted complete otoacoustic evaluations in 
all children regardless of Jerger score.
Distortion product otoacoustic  emissions 
(DPOAEs). In the present study we used 
DPOAEs as an objective measure of hearing 
function at 45 months of age. OAEs are sounds 
of cochlear origin, which can be recorded in the 
ear canal. They are a by‑product of a vulner‑
able active feedback mechanism, located in 
the cochlear outer hair cells, which contribute 
greatly to the remarkable sensitivity and 
frequency discrimination of hearing (Kemp 
2002). Because both the OAE response level 
and the hearing threshold level depend on the 
effectiveness of the outer hair cell amplification, 
OAEs can be used as an effective diagnostic tool 
for detecting hearing loss of cochlear origin. 
In DPOAE experiments, a stimulus consisting 
of two nearby frequencies, f1 and f2, is deliv‑
ered in the ear canal. The acoustic stimuli 
are transmitted through the middle ear and 
reach the cochlea, where they propagate longi‑
tudinally as traveling waves along the basilar 
membrane (BM). Each frequency component 
f of the stimulus is amplified and absorbed 
at a characteristic resonant place x(f) on the 
BM. The nonlinearity of the BM response 
accounts for the generation of DPOAEs. 
In the cochlear region, near x(f2), that is 
simultaneously excited by both frequencies, 
 traveling waves are generated at the frequency 
fDP = 2f1 – f2 (Shera and Guinan 1999). These 
waves are transmitted back through the middle 
ear, and eventually recorded in the ear canal, 
as DPOAEs. For this reason, the DPOAE 
signal recorded at the fDP frequency is asso‑
ciated with the cochlear functionality at the 
characteristic frequency of its generation place 
(f2), both in the data  presentation and in the 
diagnostic interpretation.
Relationship between DPOAEs and 
pure-tone audiometry. When possible, the 
sensitivity of hearing is directly assessed by 
pure‑tone audiometry, a behavioral technique 
that measures the hearing threshold, defined 
as the minimum pure tone level producing 
perception, at a set of standard frequencies. 
Unfortunately, this technique requires the 
active collaboration of the subject (e.g., hand 
raise, button press, verbal response), and is 
less reliable when applied to 45‑month‑old 
children (Beahan et al. 2012). In adults, 
DPOAEs are correlated with hearing 
threshold (as assessed by pure‑tone audiom‑
etry), as established in several cross‑sectional 
studies (e.g., Bonfils et al. 1988; Gorga et al. 
1993; Moulin et al. 1994; Nieschalk et al. 
1998; Sisto et al. 2007). As noted by Engdahl 
et al. (2013), unlike pure‑tone audiometry, 
OAEs are less influenced by inner hair cell 
function, and they may therefore serve as a 
more sensitive measure of cochlear function 
compared with pure‑tone audiometry.
Assessment and analysis of DPOAEs in 
present study. Children were examined 
while sitting in a soundproof room, and the 
manufacturer’s protocol was followed. For 
a quiet and cooperative child, the DPOAE 
measurement took < 10 min. DPOAEs 
were recorded using the Echoport ILO 292 
USB‑I (Otodynamics Ltd., Hatfield, Herts., 
UK), in response to pairs of primary tones of 
nearby frequencies, f1 and f2, with f2 varied in 
one‑fourth–octave steps between 1,000 and 
5,657 Hz, using a constant frequency ratio 
f2/f1 = 1.22. Both primary levels were set to 
70 dB SPL (decibel sound pressure level). 
For each frequency step, a signal analyzer 
picked up the DPOAE response component 
at the fDP frequency, producing amplitude 
spectra called DP‑grams. The associated noise 
floor was rather constant across subjects, so 
the DPOAE signal‑to‑noise ratio (SNR) 
was strongly correlated to the response level. 
Jusko et al.
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Because the detection of hearing impair‑
ment is associated with decreased levels of 
the DPOAE response, rejecting data with 
low SNR would introduce a serious bias in 
the data analysis. For this reason, our choice 
was to include all the data in the analysis, 
adopting the choice of attributing half the 
noise amplitude (noise – 6dB) to all signal 
levels below this threshold. Although the 
quantitative meaning of DPOAE levels lower 
than the noise is certainly questionable, our 
purpose was to avoid the systematic error that 
is always associated with using an SNR‑based 
data selection criterion when the outcome 
variable is strongly correlated with SNR itself.
Of the 441 children who initially visited the 
district hospital for follow‑up, DPOAEs were 
completed on 351 (81%) children. Reasons 
that the DPOAE could not be conducted or 
the reading was not valid included the child 
not staying still or the child having upper 
respiratory/ear conditions such as acute sinus‑
itis or inflammation of the middle ear/acute 
tubotympanic catarrh at the time of testing 
at 45 months. For these 351 children with 
DPOAE data, 193 had at least one DPOAE 
frequency measurement in both ears, whereas 
93 children had DPOAE measures in the left 
ear only, and 65 children in the right ear only.
Measurement of covariates. After the 
original enrollment at the time of delivery, 
trained nursing staff administered a question‑
naire during the 5‑day hospital stay to obtain 
information on lifestyle, diet, and living 
environment, past pregnancies and medical 
conditions, medication use before and during 
pregnancy, and socio demographic data. 
Romani ethnicity was assigned if the ethnic 
origin of either of the mother’s parents was 
Romani, the Romani language was spoken 
at home, or the mother was planning to 
raise her child with the Romani language; 
this definition matched well with addi‑
tional information, such as the family’s last 
name. Otherwise, ethnicity was assigned as 
Slovak/other neighboring European. Other 
variables, obtained for the 3 months before 
conception and during pregnancy, included 
maternal smoking and alcohol use and the 
mother’s history of illness, including respi‑
ratory symptoms, asthma, or allergy. At the 
16‑ and 45‑month follow‑up visits, mothers 
again completed questionnaires to update 
demographic, lifestyle, and dietary informa‑
tion. When the child was 45 months, mothers 
were also asked questions related to the child’s 
hearing, whether the child had experienced 
loud noise, whether any member of the family 
had experienced permanent hearing loss and, 
if so, whether the cause was congenital. We 
also verified that no child was administered 
potentially ototoxic drugs such as intravenous 
aminoglycoside antibiotics or vancomycin, 
antimalarials, or chemotherapeutic agents.
From medical records abstracted at birth, 
16, and 45 months, we obtained the child’s 
birth weight, gestational age (weeks), and 
weight at well‑ and sick‑child visits with their 
pediatricians. Of particular concern for this 
analysis, diagnoses of otitis media between 
birth and 16 months of age were abstracted.
Statistical methods. Selection of PCB 
congeners. Although we determined the 
concentrations of 15 PCB congeners in 
serum specimens, we focused our analyses 
on PCB‑153 for two reasons: a) PCB‑153 is 
highly correlated with total PCB concentra‑
tion in this cohort (Jusko et al. 2010), and 
b) it was detectable in the vast majority of 
maternal and child specimens, which facili‑
tated comparisons in effect size across time (as 
opposed to a summed measure with different 
congeners contributing to the sum at each 
time point). All maternal, cord, and child 
PCB‑153 concentrations were above the limit 
of detection (LOD), except for one sample 
at 6 months and one sample at 16 months. 
Where PCB‑153 concentrations were below 
the LOD, we used the values as reported 
by the laboratory. The “postnatal average” 
PCB‑153 concentration was estimated by 
computing the area under the serum PCB 
curve (AUC) from 6 through 45 months of 
age. Dividing the AUC by the 39‑month age 
span yields an average concentration expressed 
in nanograms per milliliter or nanograms per 
gram lipid.
Before evaluating the association between 
PCBs and DPOAE measures, participants 
in the 45‑month follow‑up were compared 
with those in the original Michalovce birth 
cohort with regard to sociodemographic 
factors and maternal PCB‑153 concentra‑
tion. Correlations of PCB‑153 concentrations 
across time points were also examined, and 
results are presented in text. Further, descrip‑
tive statistics for the DPOAEs and correla‑
tions comparing the right and left ears were 
computed, along with correlations within 
each ear across different frequencies, and are 
also presented in text.
Multivariate model. In most cases, 
previous research using DPOAEs as measures 
of ototoxicity have modeled each ear sepa‑
rately as a function of a set of covariates, or 
simultaneously modeled both ears, ignoring 
their inherent correlation. In the present 
analysis, we fit multivariate generalized linear 
models that accounted for the correlated 
nature of the data, because of the repeated 
assessment of the DPOAE for a given child 
in each ear, and at 11 test frequencies. This 
hierarchical approach was chosen because 
it a) provides a more powerful analysis by 
simultaneously evaluating measures of the left 
and right ears as well as different frequencies 
measured in each ear, via a single statistical 
model (e.g., each of our models contained 
approximately 5–6,000 observations); and 
b) accounts for the complex pattern of 
within‑child correlation (both across frequen‑
cies and across ears), to obtain valid estimates 
of model coefficients and their standard 
errors. In statistical models, PCB‑153 concen‑
trations (nanograms per milliliter) were 
transformed using the natural log to reduce 
the influence of extreme values. For each 
of the six PCB exposure time points (e.g., 
maternal, cord, 6‑month infant, 16‑month 
infant, 45‑month child, and postnatal 
average), we first built a core model, before 
adding potential confounders, that included 
the corresponding natural log transformed 
PCB exposure (nanograms per milliliter), 
frequency, side, and the interaction between 
side and frequency. We initially considered 
interactions between frequency, side, and 
PCB concentration to allow for possible 
differences in the PCB–DPOAE associations 
at specific frequencies for the two ears, but 
did not observe any meaningful evidence of 
heterogeneity in the PCB–DPOAE associa‑
tion. Thus, the results presented here include 
only an interaction between frequency and 
side in the model. To account for the correla‑
tions of the multiple measurements within a 
child, we used as a covariance structure the 
direct product of an unstructured matrix 
(modeling covariance across the two ears) 
with an autoregressive matrix (modeling cova‑
riance across the 11 frequencies). Adjusted 
models were then constructed by adding 
confounders to the six core models. All 
models were implemented using the MIXED 
procedure in SAS (version 9.3; SAS Institute 
Inc., Cary, NC, USA).
Selection of potential confounding 
variables. We initially selected potential 
confounding variables based on a graphical 
approach using directed acyclic graphs 
(DAGs) (Greenland et al. 1999). Separate 
DAGs were created for each of the six PCB 
measures. The potential confounding vari‑
ables chosen for each DAG were dependent 
on the model, and included ethnicity, lipid 
concentration, and child’s sex, weight, age, 
and breastfeeding duration. The constructed 
DAGs were used to select minimal sufficient 
adjustment sets, but we found empirically 
that only adjustment for ethnicity meaning‑
fully changed our estimated associations. In 
addition to the variables considered in our 
DAG, we also considered the number 
of diagnosed episodes of otitis media the 
child had between birth and 16 months of 
age, abstracted from medical records, even 
though this variable may lie on the causal 
pathway of PCB concentration and DPOAE 
amplitude, because some literature suggests 
a positive association between PCB concen‑
trations and otitis media (Chao et al. 1997; 
Dallaire et al. 2006). We also fit models that 
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excluded children with congenital hearing 
loss and children whose mothers reported, at 
45 months, that the child was exposed to loud 
noise during childhood. Even with additional 
adjustment or restriction, we found little 
difference in the estimated PCB–DPOAE 
associations; thus, these variables were not 
considered further, and our adjusted results 
are presented with adjustment for ethnicity 
only (Romani vs. Slovak/other European).
Results
Descriptive characteristics of the study sample. 
Table 1 shows the characteristics of the 351 
children who had a DPOAE measured in at 
least one ear for at least one frequency, and 
those from Michalovce in the original cohort 
(n = 812). Overall, these two groups were 
quite similar, except for ethnicity. Romani 
families were less likely to participate in the 
hearing study at 45 months compared with 
Slovak or other European families (comprising 
16% of the study sample at 45 months vs. 
21% at birth; Table 1) (p = 0.02). Maternal 
PCB‑153 concentrations were highly similar 
among participants in the present study 
and the entire Michalovce cohort at birth 
(p = 0.99). Gestation length was inversely 
associated with maternal PCB‑153 concen‑
tration, whereas maternal age was positively 
associated with PCB‑153 concentration. 
At 45 months, child PCB‑153 concentra‑
tion was higher among Romani children, 
and was strongly related to breastfeeding 
duration. Romani women also reported longer 
breastfeeding duration compared to Slovak/
European women (data not shown).
PCB concentrations. Median maternal 
serum concentrations of PCB‑153 among 
mother–child pairs with complete model 
data were 169 ng/g lipid [interquartile range 
(IQR), 117–266 ng/g lipid] (Table 2). Cord 
blood concentrations tended to be lower than 
maternal concentrations (median, 130 ng/g 
lipid). Median child serum concentrations of 
PCB‑153 were 141 ng/g lipid at 6 months 
of age (IQR, 41–265), 138 ng/g lipid at 
16 months of age (IQR, 41–341 ng/g lipid), 
and 121 ng/g lipid at 45‑months of age (IQR, 
45–268 ng/g lipid). The median postnatal 
average PCB‑153 concentration, calculated for 
291 children with complete PCB concentra‑
tions for 6–45 months was 140 ng/g lipid. 
The Spearman correlations of lipid‑adjusted 
PCB‑153 measurements between maternal 
and cord were strongly correlated [rho 
(ρ) = 0.91], as were the individual, age‑specific 
postnatal concentrations (0.87 ≤ ρ ≤ 0.93). 
The postnatal average concentration was 
strongly correlated with each postnatal 
measurement (0.93 ≤ ρ ≤ 0.98), but less so 
with maternal (ρ = 0.34) and cord concentra‑
tions (ρ = 0.37) (p‑values for all correlations 
were < 0.001).
DPOAE descriptive statistics .  The 
mean ± SE of DPOAE measures by ear and 
frequency are shown in Figure 1. Overall, 
the mean response (decibels SPL) was greater 
in the right versus the left ear, though this 
difference tended to decrease as frequencies 
increased. The variability in DPOAE 
measures was generally constant across 
frequencies and ears.
DPOAE measures were positively corre‑
lated within an individual. For instance, 
the Pearson correlation of left with right 
Table 1. Characteristics and PCB-153 concentrations of mothers and children in the Michalovce cohort 
and those with hearing data at 45 months of age.
Characteristic
Michalovce 
cohort 
n = 812 [n (%)]a
45-month 
follow-up  
n = 351 [n (%)]a p-Valueb
Median PCB-153 conc (ng/g lipid) 
Maternal 
(n = 754)
45-month child 
(n = 351)
Infant sex
Male 423 (52) 175 (50) 0.48 170 135
Female 389 (48) 176 (50) 169 104
Gestation length (weeks)
< 37 18 (2) 3 (1) 0.37 206 89
37–41 761 (94) 333 (95) 171 126
≥ 42 23 (3) 12 (3) 137 58
Missing 10 (1) 3 (1) 92 154
Maternal education (years)
< 12 324 (40) 122 (35) 0.20 167 104
12–16 412 (51) 202 (57) 171 120
> 16 47 (6) 17 (5) 168 213
Missing 29 (3) 10 (3) 171 143
Ethnicity of child
Romani 174 (21) 55 (16) 0.02 158 140
Slovak/eastern European 638 (79) 296 (84) 172 107
Marital status
Married 719 (89) 319 (91) 0.67 169 124
Never married 57 (7) 20 (6) 173 93
Divorced/separated 7 (1) 3 (1) 259 53
Missing 29 (3) 9 (2) 163 160
Maternal age (years)
18 to < 20 68 (8) 27 (8) 0.91 114 126
20–30 614 (76) 266 (76) 160 106
> 30 130 (16) 58 (17) 228 205
Breastfeeding (months)
None — 12 (3) 175 19
> 0–6 — 190 (54) 170 60
> 6–12 — 52 (15) 156 180
> 12–18 — 56 (16) 167 309
> 18 — 38 (11) 166 365
Missing — 3 (1) 171 17
Maternal PCB-153 (ng/g lipid)
Mean ± SD (median) 226 ± 225 (170) 226 ± 183 (168) 0.99
conc, concentration.
aPercentages may not sum to 100 because of rounding. bp-Value compares the distribution of characteristics in the 
Michalovce cohort (n = 812) with those with hearing data at 45 months (n = 351). Chi-square test was used for categorical 
variables, and t-test for quantitative variables (PCB concentrations).
Table 2. Serum PCB-153 concentrations among participants with complete model data for each 
exposure.
PCB-153 exposure n Mean Min P10 P25 P50 P75 P90 Max
Wet weight (ng/ml)
Maternal 319 2.31 0.43 0.84 1.13 1.68 2.74 4.44 12.87
Cord 334 0.46 0.05 0.14 0.21 0.31 0.52 0.95 4.27
6-month infant 326 1.41 0.01 0.11 0.24 0.84 1.63 3.13 19.55
16-month infant 320 1.56 0.00 0.11 0.26 0.73 1.80 3.44 16.21
45-month child 345 1.21 0.02 0.12 0.23 0.67 1.53 2.71 11.52
Postnatal average 291 1.46 0.05 0.13 0.28 0.81 1.73 3.17 13.63
Per lipid (ng/g)
Maternal 317 226 46 79 117 169 266 445 1,273
Cord 334 184 14 62 84 130 208 367 1,373
6-month infant 323 224 2 16 41 141 265 499 2,641
16-month infant 318 268 1 18 41 138 341 545 3,504
45-month child 344 210 4 21 45 121 268 467 1,919
Postnatal average 291 250 8 22 48 140 304 509 2,435
Abbreviations: Max, maximum; Min, minimum; P, percentile.
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ear DPOAEs varied from 0.45 to 0.69, 
depending on the frequency. In all cases, they 
were statistically significant at the p < 0.001 
level. Additionally, the Pearson correlation 
between different frequencies within ears 
varied from 0.16 to 0.89 (p < 0.01 for all 
frequencies) for the left ear, and from 0.28 
to 0.88 (p < 0.0001 for all frequencies) for 
the right ear. Correlations within an ear 
were higher for DPOAE frequencies that 
were closer and declined as the frequency 
 differences increased.
Associations of PCB-153 concentrations 
with DPOAE measurements. Overall, Table 3 
indicates that postnatal rather than in utero 
(maternal and cord blood) PCB‑153 concen‑
trations are associated with adverse DPOAE 
amplitudes. After adjustment for ethnicity, 6‑, 
16‑, and 45‑month PCB‑153 concentrations 
were all inversely associated with DPOAEs 
assessed at 45 months, with approximately the 
same magnitude of association (a decrease of 
about 1 dB SPL as PCB‑153 concentration 
increased from the 25th to 75th percentile). 
When all postnatal PCB exposures were 
considered as a cumulative, AUC metric 
(“postnatal average”), an increase from the 25th 
to the 75th percentile in postnatal PCB‑153 
concentration was associated with a 1.57 lower 
dB SPL (95% CI: –2.61, –0.53; p = 0.003). 
In addition, compared with Slovak/other 
European children, Romani children had 
significantly lower DPOAE amplitudes (about 
3 dB SPL lower on average) (data not shown).
When we adjusted for additional poten‑
tial confounders (breastfeeding duration, lipid 
concentration, and child’s age, weight, and 
sex), the “postnatal average” estimate was not 
meaningfully different, and was in fact further 
from the null (results not shown). In addition, 
we considered the number of episodes of 
otitis media between birth and 16 months 
as a potential confounder. History of otitis 
media was inversely associated with DPOAEs; 
specifically, as the number of such episodes 
increased from zero to one, or from one to 
two or more, DPOAE amplitudes dropped 
by > 2 dB SPL (data not shown). However, 
there was no evidence of confounding by 
otitis media, as we did not observe meaning‑
fully different estimates of the PCB–DPOAE 
 association after adjustment.
Discussion
In the present study, we observed an inverse 
association between postnatal serum PCB 
concentrations and DPOAE amplitudes 
measured at 45 months. Measures of in utero 
PCB concentration—namely, the maternal 
and cord blood sample at delivery—were 
not associated with DPOAE amplitudes 
at 45 months.
Previous studies from a different group of 
children from this region have demonstrated 
cross‑sectional associations between child 
PCB concentrations and hearing impair‑
ment at 8–9 years (Trnovec et al. 2008) 
and at 12 years of age (Trnovec et al. 2010). 
At 12 years of age, reduced power of tran‑
sient evoked otoacoustic emissions and 
DPOAEs were observed at the low frequen‑
cies in relation to the child’s current PCB 
concentrations. These studies examined 
only cross‑sectional associations, and PCB 
concentrations at 8–9 and 12 years of age 
are probably less reflective of perinatal 
exposure; thus, it is unclear whether expo‑
sures earlier in life would also be associ‑
ated with reduced OAE amplitudes. In the 
Collaborative Perinatal Project conducted in 
the 1960s in the United States, Longnecker 
et al. (2004) found no association between 
prenatal measurements of PCBs measured 
in maternal serum samples taken during 
pregnancy and sensorineural hearing loss 
(based on hearing thresholds) in offspring 
at 8 years of age. In our analysis, we also did 
not observe any association with maternal 
PCB concentration; only the postnatal PCB 
concentrations were associated with lower 
DPOAE levels at 45 months of age. On the 
other hand, higher in utero PCB concentra‑
tions (as reflected by umbilical cord concen‑
trations) were associated with increased 
hearing thresholds (Grandjean et al. 2001) 
in the fish‑eating population of the Faroe 
Table 3. Associations between pre- and postnatal PCB-153 concentrations (ng/mL) and 45-month DPOAE 
amplitudes.
Exposure n (obs)a β (95% CI)b
75th vs. 25th 
percentile (95% CI)c p-Valued
Maternal
Unadjusted 319 (5,504) 0.69 (–0.37, 1.75) 0.61 (–0.33, 1.55) 0.20
Adjusted for ethnicity 319 (5,504) 0.50 (–0.53, 1.53) 0.44 (–0.47, 1.35) 0.34
Cord
Unadjusted 334 (5,713) 0.72 (–0.26, 1.70) 0.66 (–0.24, 1.56) 0.15
Adjusted for ethnicity 334 (5,713) 0.58 (–0.36, 1.53) 0.54 (–0.33, 1.41) 0.22
6-month child PCB-153
Unadjusted 326 (5,559) –0.52 (–1.04, 0.00) –0.99 (–1.98, –0.01) 0.05
Adjusted for ethnicity 326 (5,559) –0.50 (–1.01, 0.02) –0.94 (–1.93, 0.04) 0.06
16-month child PCB-153
Unadjusted 320 (5,450) –0.57 (–1.06, –0.08) –1.11 (–2.05, –0.16) 0.02
Adjusted for ethnicity 320 (5,450) –0.51 (–0.98, –0.04) –0.98 (–1.89, –0.08) 0.03
45-month child PCB-153
Unadjusted 345 (5,878) –0.60 (–1.16, –0.04) –1.13 (–2.19, –0.07) 0.04
Adjusted for ethnicity 345 (5,878) –0.56 (–1.12, –0.01) –1.06 (–2.11, –0.01) 0.05
Postnatal average PCB-153
Unadjusted 291 (4,966) –0.92 (–1.51, –0.33) –1.67 (–2.74, –0.60) 0.002
Adjusted for ethnicity 291 (4,966) –0.86 (–1.44, –0.29) –1.57 (–2.61, –0.53) 0.003
aNumber of participants in each model, where the reduction from 351 is attributable to missing PCB-153 concentration 
only; the number of observations (obs) included in each multivariate model is also noted. bEstimated change in DPOAE 
amplitude (dB SPL) for each 1-natural log unit increase in the corresponding PCB-153 exposure (wet weight, ng/mL). 
cEstimated change in DPOAE amplitude (dB SPL) for an increase in the corresponding PCB-153 concentration (wet 
weight, ng/mL) from the 25th to the 75th percentile. dCorresponding p-value for each regression model.
Figure 1. Mean ± SE of distortion product otoacoustic emission (DPOAE) outcomes by frequency, for left 
(n = 286) and right (n = 258) ears.
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Islands. However, as noted by Longnecker 
et al. (2004), PCB concentrations in the 
Faroese cohort were approximately three 
times greater than the maternal PCB concen‑
trations in the Collaborative Perinatal Project. 
A similar magnitude of difference comparing 
the Faroese cohort with the present study is 
also apparent (where the Faroese concentra‑
tions are approximately three times greater). 
Thus, it is possible that a threshold for 
prenatal ototoxicity exists, with maternal/
cord concentrations in the Slovak children’s 
cohort falling below the threshold for an 
adverse association with cochlear function. 
In neither the Collaborative Perinatal Project 
(Longnecker et al. 2004) nor the Faroe Island 
study (Grandjean et al. 2001) were postnatal 
PCB concentrations analyzed in relation 
to hearing thresholds. Because of this, it is 
unknown whether the Collaborative Perinatal 
Project would have observed associations 
similar to those in the present study or not 
(no association with in utero exposure, but 
with postnatal exposure), or whether post‑
natal PCB concentrations, in addition to cord 
blood PCB concentrations, were associated 
with hearing thresholds in the Faroese cohort.
We also observed that DPOAE measures 
were generally greater in the right ear compared 
with the left ear. This finding is consistent 
with some but not all previous research. For 
instance, higher DPOAE levels in the right ear 
have been reported in some studies (Keogh 
et al. 2001), whereas other studies found no 
meaningful left–right asymmetry (Pavlovčinová 
et al. 2010). We did not observe an interaction 
by ear at 45‑months—the relationship between 
DPOAE measures and PCBs did not differ in 
the left versus right ear.
The OAE levels are fairly constant through 
life, at least before the onset of presbyacusia 
or any other cochlear disturbances (Engdahl 
et al. 1994; Franklin et al. 1992; Kemp et al. 
1986; Prieve et al. 1993). Maturation of the 
cochlear amplifier in the first months of life 
is still the object of discussion. At 6 months 
of age, although anatomical, electrophysi‑
ological, and psychoacoustic data suggest full 
cochlear functional maturity, immaturity of 
the DPOAE suppression tuning curves has 
been reported (Abdala et al. 2007), probably 
also related to developmental changes in the 
middle ear transmission. Thus, although we 
observed associations between all the postnatal 
exposures examined and DPOAE amplitudes, 
it may be that PCB is ototoxic only in the 
first few months of life, when exposure to 
PCBs is greatest as a result of early, exclusive 
breastfeeding. Specifically, duration of exclu‑
sive breastfeeding has been strongly associ‑
ated with individual and cumulative (AUC) 
measures of infant serum PCB concentrations 
in this cohort (Jusko et al. 2012; Trnovec 
et al. 2011) and others (Ayotte et al. 2003). 
Moreover, in a study of Inuit infants, Ayotte 
et al. (2003) modeled 6‑month infant plasma 
concentrations of PCB‑153 as a function 
of maternal PCB‑153 concentration and 
breastfeeding duration. In the model that 
included only maternal PCB‑153 concentra‑
tion as a predictor, the R2 value was 0.08; 
however when breastfeeding duration was 
added as an additional predictor, the model 
R2 was 0.66, strongly suggesting that most 
of the variance in postnatal PCB concentra‑
tions is explained by breastfeeding duration 
rather than maternal PCB concentrations. 
Although this study was conducted in a 
different population, maternal PCB exposures 
were of similar magnitude, as was the duration 
of total breastfeeding (Verner et al. 2013). 
Thus, the adverse associations between 16‑ 
and 45‑month PCBs and 45‑month DPOAE 
amplitudes may be attributable simply to the 
strong, positive correlations between postnatal 
PCB‑153 measures over time. On the other 
hand, there may be continued development 
of hearing mechanisms beyond 6 months 
of age, and the results we observed between 
later PCB measures and 45‑month DPOAE 
amplitudes may be evidence of continued 
ototoxicity. Interestingly, we observed the 
strongest adverse associations with DPOAE 
amplitudes with postnatal average PCB‑153 
concentration, an exposure metric that takes 
into account all postnatal PCB measurements 
using an AUC approach. This may support 
the hypothesis that duration of PCB exposure, 
rather than a specific time period, is most 
critical to hearing development; or it may 
simply be that the postnatal average metric 
reduces PCB exposure misclassification and 
thus effect estimate attenuation toward the 
null hypothesis. Although a sensitive window 
for structurally related cochlear impairment 
would likely originate during prenatal devel‑
opment—in which case the optimal marker 
would be the PCB concentration in maternal 
or cord blood—deficits in cochlear function 
that develop postnatally in infancy or beyond 
may result from alternative mechanisms, 
mediated by PCB concentrations measured 
later. These mechanisms include alteration 
of intracellular Ca2+ signaling via ryanodine 
receptor–activated Ca2+ stores and reactive 
oxygen species, as discussed by Powers et al. 
(2006), though these hypotheses may not be 
extrapolatable to humans.
DPOAE measurements were recorded 
and analyzed in multivariate models. Notably, 
the strong correlations of DPOAEs at 
different frequencies and between the right 
and left ears dictated that we account for the 
non‑independence of the multiple measure‑
ments taken on each child. We accomplished 
this by fitting generalized multivariate 
linear models in which the covariances were 
assumed to be unstructured between ears, 
and autoregressive according to the frequency 
tested, based on examination of the pairwise 
DPOAE correlations across frequencies. 
This allowed for a single estimate of asso‑
ciation across ears and frequency, which 
used between 5 and 6,000 observations per 
model to estimate the PCB–DPOAE asso‑
ciation, increasing statistical power consid‑
erably over analyses that would stratify by 
frequency and ear.
In the final models for 45‑month PCB 
measurements, we adjusted for ethnicity, 
and Romani children had significantly lower 
DPOAE amplitudes (about 3 dB SPL lower 
on average). In secondary analyses where we 
adjusted for the number of episodes of otitis 
media between birth and 16 months, we 
observed strong inverse associations between 
a history of these infections and DPOAEs. 
More specifically, as the number of such 
episodes increased from zero to one, or from 
one to two or more, DPOAE amplitudes 
dropped by > 2 dB SPL. Otitis media has 
been associated with prenatal PCB expo‑
sures (Dallaire et al. 2006), and may there‑
fore function as an intermediate variable. 
However, inclusion of these infections in the 
model as a confounder of the PCB–DPOAE 
relationship did not alter the primary results 
of interest: The relationship between postnatal 
PCB level and DPOAE was not altered; nor 
was it affected by inclusion of breastfeeding 
duration, congenital hearing loss in another 
family member, or exposure to loud noise. 
Overall, the results appear to be quite robust 
to the choice of control variables, supporting 
a minimal level of confounding. Putting our 
results into perspective, although we observed 
associations between postnatal PCB exposures 
and DPOAE amplitudes, the adverse PCB 
association was never greater than the associa‑
tion between ethnicity or ear infections and 
DPOAE amplitudes.
A major strength of this study is the 
design, involving multiple PCB measures 
covering prenatal, infant, and later exposures, 
which provided the ability to assess potential 
critical exposure windows. We focused on 
PCB‑153 as the exposure of interest because 
it is highly correlated with other PCBs in 
our population and with total PCB concen‑
tration, and it is detectable in nearly all 
samples (Jusko et al. 2010). In fact, PCB‑153 
comprises approximately 34% (together 
with di‑ortho–substituted PCBs 138 and 
180, about 80%) of the concentration of the 
total sum of PCBs in serum in this popu‑
lation. On the other hand, other congeners 
with different structure–activity relationships 
(e.g., non‑ortho substituted dioxin‑like PCBs) 
might show different associations. However, 
these congeners are not reliably detectable 
using high‑resolution gas chromatography, 
which is a limitation of our study.
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Although we had substantial attrition in 
our study, participation in the follow‑up was 
not related to PCB exposure. Nonetheless, 
if loss to follow‑up was associated with 
DPOAEs’ being conditional on postnatal 
PCB levels, some selection bias could have 
occurred. Further, we observed greater attri‑
tion among Romani families, but inclusion 
of ethnicity as a covariate should reduce the 
effects of selection. Although we focused on 
PCBs, interaction with other ototoxic agents 
is possible, and is a potential weakness of 
our study. For instance, in rats, combined 
exposure to doses of PCBs and polybromi‑
nated diphenylethers (PBDEs) that, by 
themselves, were without effect, did produce 
significant hearing loss, indicating that PBDEs 
have the potential to interact with PCBs in 
producing hearing loss (Poon et al. 2011).
On balance, this study adds further 
evidence to a growing body of literature in 
both rodents and humans suggesting cochlear 
dysfunction with increased exposure to PCBs. 
The mechanisms for an impact of postnatal 
PCB exposure versus prenatal PCB exposure 
remain to be clarified.
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